PRESS RELEASES
Seed Therapeutics has completed construction of a new state of the art innovation and research center at 411 Swedeland Road in King of Prussia, Pennsylvania.
King of Prussia, PA – July 01, 2022 – Seed Therapeutics has completed construction of a state of the art 10,000 square foot innovation and research center including 7,000 square feet of cutting edge lab space at 411 Swedeland Road in King of Prussia, Pennsylvania.
LATEST PRESS RELEASES
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
info@seedtherapeutics.com info@seedtherapeutics.com PRESS RELEASESBeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly Seed Therapeutics to Use Proprietary “Molecular Glue” Protein Degradation Technology to...
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
info@seedtherapeutics.com info@seedtherapeutics.com PRESS RELEASESSeed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer “Molecular Glue” Protein Degradation Serves as Alternative Approach for...